Antonio D'Avolio
机构: University of Turin, Medical Sciences Dpt., Lab. Clinical Pharmacology and Pharmacogenetics
每年引用次数
引用次数
引用: 8,483
H-指数: 46
I10-指数 : 205
出版物: 600
Impairment in Kidney Tubular Function in Patients Receiving Tenofovir Is Associated with Higher Plasma Tenofovir Levels
P Labarga , M Albalater , S Bonora , M Siccardi
16th CROI
7
2009
A Population Pharmacokinetic Model Illustrates an Association Between a Pregnane-X-Receptor (PXR) Polymorphism and Boosted Atazanavir Clearance
A Schipani , M Siccardi , M Boffito , A D’Avolio
17th Conference on Retroviruses and Opportunistic Infections (CROI)
2010
Intracellular Pharmacokinetics of ATV/RTV Is Influenced by Solute Carrier Organic Anion Transporter 3A1 Expression
M Siccardi , A D’Avolio , L Baietto , M Simiele
18th CROI
2011
TCH-042 Stability Study of Ganciclovir in 0.9% Sodium Chloride in Different Types of Containers: Optimization of Resources
C Tomasello , MM Giacomotti , A D’Avolio , M Simiele
European Journal of Hospital Pharmacy 20 ( 11)
1
2013
Antiretroviral concentrations in the presence and absence of valproic acid
A Calcagno , J Cusato , M Ferrara , A De Nicolò
Journal of Antimicrobial Chemotherapy 75 ( 7) 1969 -1971
1
2020
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV
A Borghetti , A Calcagno , F Lombardi , J Cusato
Journal of Antimicrobial Chemotherapy 74 ( 4) 1035 -1043
10
2019
Undetectable antimicrobial plasma concentrations in an HIV-positive patient with protein-losing enteropathy and chylothorax during Mycobacterium genavense and Leishmania abdominal infections.
I Motta , M Trunfio , A Calcagno , V Pirriatore
Journal of Antimicrobial Chemotherapy 73 ( 2) 546 -548
1
2018
Virological Failure in HIV to Triple Therapy With Dolutegravir-Based Firstline Treatment: Rare but Possible.
M J Pena , N Chueca , A D’Avolio , J M Zarzalejos
Open Forum Infectious Diseases 6 ( 1)
7
2019
Altered plasma levels of nevirapine after commencing rifampicin containing TB regimens in Malawi
Mas Chaponda , W Nyirenda , V Watson , S White
HIV MEDICINE 11 6 -6
2010
The HOCT1/ABCB1 polymorphisms don’t condition the cytogenetic and molecular response or tolerability to first-line nilotinib in chronic myeloid leukemia patients
S Galimberti , C Bucelli , E Arrigoni , C Baratè
HAEMATOLOGICA 101 ( suppl. 3) S101 -S102
2016
genotypic inhibitory quotient (gIQ) predicts early virological response to TPV-based salvage regimens
S Bonora , D Gonzalez de Requena , A Calcagno , MG Milia
13th Conference on Retroviruses and Opportunistic Infections 5 -8
6
2006
P301 Interactions between HIV and HCV therapies: how common and who wins?
A Torkington , J Barnes , S Cripps , K Lee
P166
C Alcantarini , M Ferrara , M Tettoni , F Lipani
Official statement of the section of Clinical Pharmacology of the Italian Society of Pharmacology on the use of ACE-inhibitors or angiotensin receptor blockers in COVID-19 infection
G Trifirò , L Berrino , M Del Re , R Bernardini
Soc Ital di Farmacol 2 1 -5
1
2020
Treatment of high baseline viral load chronic hepatitis B using sequential therapy with entecavir and PEG-IFN
L Boglione , CS Cardellino , A De Nicolò , J Cusato
Digestive and Liver Disease 48
2016
Poster 4.19 REPEATED PHARMACOKINETICS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) IN HIV-INFECTED ADULTS RECEIVING SAQUINAVIR (SQV) HARD GEL/RITONAVIR (RTV) 1000/100 MG BID
M Boffito , A D’Avolio , G Di Perri , M Sciandra
Age (years) 45 22 -62
Gender differences in five different drug pharmacokinetics
S Allegra , S De Francia , AE Sprio , M De Gobbi
114 -114
2019
Atazanavir Ctrough is associated with efficacy and safety: definition of therapeutic range
D Gonzalez de Requena , S Bonora , F Canta , R Marrone
Age (years) 170 165 -174
80
2005
Atazanavir Ctrough is associated with efficacy and safety at 24 weeks: definition of therapeutic range
D Gonzalez de Requena , S Bonora , I Cavechia , R Marrone
6th International Workshop on Clinical Pharmacology of HIV Therapy 28 -30
17
2005
SLC22A2 genetic variants and dolutegravir trough concentrations correlate with specific psychiatric symptopms in HIV-positive patients on Dolutegravir
A Borghetti , A Calcagno , F Lombardi , J Cusato
19th International Workshop on Clinical Pharmacology of Antiviral Therapy 22 -24
1
2018